FILAMENT HEALTH ANNOUNCES FOURTH PATENT ISSUANCE
The patent describes the extraction and standardization of stable doses of psychedelic compounds VANCOUVER, BC, April 27, 2022 /CNW/ - Filament Health Corp. , a clinical-stage natural... | April 27, 2022
United States British Columbia Bryan Moss European Union Good Manufacturing Practices Trademark Office Filament Health
Source: marketscreener.com